Literature DB >> 9475335

A roadmap for HLA-DR peptide binding specificities.

G Chelvanayagam1.   

Abstract

Peptide residue positional environments have previously been defined for class I MHC allelic products. These environments provide a less restrictive description of the traditional peptide binding pockets of class I molecules. When combined with the peptide anchor motifs that have been identified for some class I molecules, predictions as to likely motifs for other MHC molecules, which share the same potential environment can be made. Here, the same approach is used to derive peptide residue positional environments for class II MHC molecules. The environments are used to make predictions as to likely binding motifs for HLA-DR allelic products. The predictions are presented in the form of a Table and shown to have concordance with experimental results.

Mesh:

Substances:

Year:  1997        PMID: 9475335     DOI: 10.1016/s0198-8859(97)00185-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  FIMM, a database of functional molecular immunology.

Authors:  C Schönbach; J L Koh; X Sheng; L Wong; V Brusic
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  FIMM, a database of functional molecular immunology: update 2002.

Authors:  Christian Schönbach; Judice L Y Koh; Darren R Flower; Limsoon Wong; Vladimir Brusic
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

3.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

4.  Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

5.  The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease.

Authors:  Hidefumi Inaba; William Martin; Matt Ardito; Anne Searls De Groot; Leslie J De Groot
Journal:  J Clin Endocrinol Metab       Date:  2010-04-14       Impact factor: 5.958

6.  BlockLogo: visualization of peptide and sequence motif conservation.

Authors:  Lars Rønn Olsen; Ulrich Johan Kudahl; Christian Simon; Jing Sun; Christian Schönbach; Ellis L Reinherz; Guang Lan Zhang; Vladimir Brusic
Journal:  J Immunol Methods       Date:  2013-08-31       Impact factor: 2.303

7.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

8.  Regression mapping of association between the human leukocyte antigen region and Graves disease.

Authors:  Matthew J Simmonds; Joanna M M Howson; Joanne M Heward; Heather J Cordell; Helen Foxall; Jackie Carr-Smith; Sarah M Gibson; Neil Walker; Yaron Tomer; Jayne A Franklyn; John A Todd; Stephen C L Gough
Journal:  Am J Hum Genet       Date:  2004-11-22       Impact factor: 11.025

9.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

10.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.